Finzati - Logo
CHE logo

Chemed Corporation

CHE • Medical - Care Facilities
$519.84
▼ -4.61 (-0.88%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$7.11B
Growth
5.4%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 10.5%Positive revenue growth · 6.5%Positive free cash flow · 22.61Consistent free cash flow · 5/5Manageable debt level · 0.16
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: Apr 23, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$519.84
Change-0.88%
Shares Out13.68M
Market Cap$7.11B
Enterprise Value$7.22B
52W Range365.21 - 562.77
Beta0.54
P/E27.36
P/S2.80
P/B8.38
P/FCF18.85
EV/Sales2.84

Investment DNA

How strong this company looks for long-term investors

77
out of 100
Business Quality
Margins, moat, returns
66/100
Financial Strength
Debt, cash, stability
77/100
Growth Potential
Revenue and expansion
81/100
Price Attractiveness
Cheap or expensive today
66/100
Why this score▼
Stable or improving margins · 10.5%Positive revenue growth · 6.5%Positive free cash flow · 22.61Consistent free cash flow · 5/5Manageable debt level · 0.16

Analyst view

Analyst sentiment and price target

CHE
Analyst sentiment
Based on 9 analyst votes · 2026-09-05
67/100
Neutral
Bullish
3
Hold
6
Bearish
0
Price Target
2026-06-25
Low
$475.00
Mean
$475.00
Median
$475.00
High
$475.00

Company Overview

IPO: 5/3/1973
Industry: Medical - Care Facilities
P/B i: 8.38
Debt / Equity i: 0.16
Operating Margin: 13.37%
Net Margin: 10.48%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.16
Current Ratio: 1.05
Quick Ratio: 1.03
Status: Good

Insider Transactions

Recent executive and insider activity

LINDELL ANDREA R
Transaction: 06/09/2026
SELL
Change
-1,347
Price
$447.33
Filing
06/10/2026
Type
SELL
WALSH GEORGE J III
Transaction: 05/29/2026
SELL
Change
-500
Price
$437.83
Filing
05/29/2026
Type
SELL
DeLyons Ron
Transaction: 05/18/2026
BUY
Change
+386
Price
$440.77
Filing
05/19/2026
Type
BUY